Literature DB >> 25187753

Abuse and misuse of antidepressants.

Elizabeth A Evans1, Maria A Sullivan1.   

Abstract

BACKGROUND: Rates of prescription drug abuse have reached epidemic proportions. Large-scale epidemiologic surveys of this under-recognized clinical problem have not included antidepressants despite their contribution to morbidity and mortality. The purpose of this review is to look specifically at the misuse of antidepressants and how this behavior may fit into the growing crisis of nonmedical use of prescription drugs.
METHODS: We conducted a comprehensive search on PubMed, Medline, and PsycINFO using the search terms "antidepressant", "abuse", "misuse", "nonmedical use", "dependence", and "addiction", as well as individual antidepressant classes (eg, "SSRI") and individual antidepressants (eg, "fluoxetine") in various combinations, to identify articles of antidepressant misuse and abuse.
RESULTS: A small but growing literature on the misuse and abuse of antidepressants consists largely of case reports. Most cases of antidepressant abuse have occurred in individuals with comorbid substance use and mood disorders. The most commonly reported motivation for abuse is to achieve a psychostimulant-like effect. Antidepressants are abused at high doses and via a variety of routes of administration (eg, intranasal, intravenous). Negative consequences vary based upon antidepressant class and pharmacology, but these have included seizures, confusion, and psychotic-like symptoms.
CONCLUSION: The majority of individuals prescribed antidepressants do not misuse the medication. However, certain classes of antidepressants do carry abuse potential. Vulnerable patient populations include those with a history of substance abuse and those in controlled environments. Warning signs include the presence of aberrant behaviors. Physicians should include antidepressants when screening for risky prescription medication use. When antidepressant misuse is detected, a thoughtful treatment plan, including referral to an addiction specialist, should be developed and implemented.

Entities:  

Keywords:  abuse; addiction; antidepressant; dependence; misuse; nonmedical use; prescription

Year:  2014        PMID: 25187753      PMCID: PMC4140701          DOI: 10.2147/SAR.S37917

Source DB:  PubMed          Journal:  Subst Abuse Rehabil        ISSN: 1179-8467


  135 in total

Review 1.  Prescription drug abuse: insight into the epidemic.

Authors:  S H Hernandez; L S Nelson
Journal:  Clin Pharmacol Ther       Date:  2010-08-04       Impact factor: 6.875

2.  Ritualistic use of fluoxetine by a former substance abuser.

Authors:  M J Goldman; L Grinspoon; S Hunter-Jones
Journal:  Am J Psychiatry       Date:  1990-10       Impact factor: 18.112

3.  Abuse potential of bupropion nasal insufflation: a case report.

Authors:  Berthold Langguth; Göran Hajak; Michael Landgrebe; Willi Unglaub
Journal:  J Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.153

4.  Abuse of tricyclic antidepressant drugs: a case series.

Authors:  Raymone Shenouda; Paul H Desan
Journal:  J Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.153

5.  Mindfulness-based stress reduction, mindfulness-based cognitive therapy, and Zen meditation for depression, anxiety, pain, and psychological distress.

Authors:  William R Marchand
Journal:  J Psychiatr Pract       Date:  2012-07       Impact factor: 1.325

6.  Amineptine dependence.

Authors:  S H Ahmed; I Haq
Journal:  J Pak Med Assoc       Date:  1994-09       Impact factor: 0.781

7.  Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.

Authors:  I M Whyte; A H Dawson; N A Buckley
Journal:  QJM       Date:  2003-05

8.  Comparison of analytical methods in the determination of two venlafaxine fatalities.

Authors:  C Long; J Crifasi; D Maginn; M Graham; S Teas
Journal:  J Anal Toxicol       Date:  1997 Mar-Apr       Impact factor: 3.367

9.  The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial.

Authors:  Linda E Wüsthoff; Helge Waal; Rolf W Gråwe
Journal:  BMC Psychiatry       Date:  2014-03-05       Impact factor: 3.630

Review 10.  The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews.

Authors:  Amy O'Donnell; Peter Anderson; Dorothy Newbury-Birch; Bernd Schulte; Christiane Schmidt; Jens Reimer; Eileen Kaner
Journal:  Alcohol Alcohol       Date:  2013-11-13       Impact factor: 2.826

View more
  19 in total

1.  Chronic exposure to fluoxetine of female mice before mating causes impaired stress resilience in female offspring.

Authors:  Chenghao Yang; Jijian Si; Lin Suo; Yan Zhang; Jie Li
Journal:  J Neural Transm (Vienna)       Date:  2019-09-04       Impact factor: 3.575

2.  Detection and quantification of synthetic cathinones and selected piperazines in hair by LC-MS/MS.

Authors:  André Niebel; Franziska Krumbiegel; Sven Hartwig; Maria Kristina Parr; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2019-12-18       Impact factor: 2.007

Review 3.  Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety.

Authors:  Kyle Simon; Stacey L Worthy; Michael C Barnes; Benjamin Tarbell
Journal:  Ther Adv Drug Saf       Date:  2015-04

4.  Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release.

Authors:  Abdelrahman R Shalabi; Donna Walther; Michael H Baumann; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2017-02-27       Impact factor: 4.418

5.  Estimation and Optimization of Composite Outcomes.

Authors:  Daniel J Luckett; Eric B Laber; Siyeon Kim; Michael R Kosorok
Journal:  J Mach Learn Res       Date:  2021-01       Impact factor: 5.177

6.  Intravenous melatonin abuse leading to recurrent aortic valve endocarditis: a case report and discussion.

Authors:  Mark B Warren; Jonathan Stabler; Melissa M Hagman
Journal:  BMC Psychiatry       Date:  2016-02-24       Impact factor: 3.630

7.  Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Authors:  Laurie S Anderson; Heidi G Bell; Michael Gilbert; Julie E Davidson; Christina Winter; Monica J Barratt; Beta Win; Jeffery L Painter; Christopher Menone; Jonathan Sayegh; Nabarun Dasgupta
Journal:  JMIR Public Health Surveill       Date:  2017-02-01

8.  Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity.

Authors:  Evangelia Liakoni; Sabine Müller; Adrian Stoller; Meret Ricklin; Matthias E Liechti; Aristomenis K Exadaktylos
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-03-07       Impact factor: 2.953

9.  Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.

Authors:  E Jennifer Edelman; Yu Li; Declan Barry; Jennifer Brennan Braden; Stephen Crystal; Robert D Kerns; Julie R Gaither; Kirsha S Gordon; Ajay Manhapra; Jessica S Merlin; Brent A Moore; Benjamin J Oldfield; Lesley S Park; Christopher T Rentsch; Melissa Skanderson; Emily C Williams; Amy C Justice; Janet P Tate; William C Becker; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

10.  Is There a Potential of Misuse for Venlafaxine and Bupropion?

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  Front Pharmacol       Date:  2018-03-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.